Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity

Shan F. Brunel, Janet A. Willment, Gordon D. Brown, Graham Devereux, Adilia Warris
ERJ Open Research 2018 4: 00068-2017; DOI: 10.1183/23120541.00068-2017
Shan F. Brunel
1Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet A. Willment
1Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Janet A. Willment
Gordon D. Brown
1Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham Devereux
2Cystic Fibrosis Clinic, Aberdeen Royal Infirmary, Aberdeen, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adilia Warris
1Aberdeen Fungal Group, MRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Supplementary Materials
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Phagocytosis and antifungal activity for phagocytes taken from healthy and CF donors. For phagocytosis (a) and fungal germination (b), polymorphonuclear cells (PMN) and monocytes (MNC) were co-incubated with FLuorescent Aspergillus REporter (FLARE) conidia in a 1:3 ratio and imaged directly with confocal microscopy. The proportion of cells containing conidia was assessed 4 h post-inoculation. Error bars indicate sem for three healthy and three CF donors. For fungicidal activity (c), PMN (5×105 per mL), peripheral blood mononuclear cells (PBMC) and MNC (2.5×106 per mL) were stimulated with Aspergillus fumigatus conidia (2.5×106 per mL) for 18 h and fungal metabolic activity was assessed with an XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay. Error bars indicate sem for eight healthy and eight CF donors for PMN and PBMC and for four healthy and four CF donors for MNC. *: p<0.05 (Mann–Whitney U-test).

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Production of reactive oxygen species (ROS) by phagocytes from healthy and CF donors. Polymorphonuclear cells (PMN) (a), peripheral blood mononuclear cells (PBMC) (b) and monocytes (MNC) (c) (2.5×106 per mL) were stimulated with Aspergillus fumigatus conidia (5×107 per mL) and chemiluminescence was measured directly (as relative light units (RLUs)·s–1 over a 2-h period). The total ROS production (d) was calculated as the area under the curve (AUC). Error bars indicate sem for four-to-six healthy and four-to-eight CF donors. *: p<0.05 (Mann–Whitney U-test).

  • FIGURE 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3

    Effect of inhibition of phagocytosis on the production of reactive oxygen species (ROS) against Aspergillus fumigatus. ROS production by polymorphonuclear cells (PMN) (a) and peripheral blood mononuclear cells (PBMC) (b) (2.5×106 per mL) is shown after pre-incubation with cytochalasin-B (Cyto-B) (5 µg·mL–1) and stimulation with Aspergillus fumigatus conidia (5×107 per mL). Error bars indicate sem for four healthy and four CF donors. RLU: relative light unit.

  • FIGURE 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4

    Pre-treatment of phagocytes from healthy and CF donors with diphenyleneiodonium chloride (DPI). The effect of DPI pre-incubation on the fungicidal activity of peripheral blood mononuclear cells (PBMC) (a) (2.5×106 per mL) and polymorphonuclear cells (PMN) (b) (5×105 per mL) against Aspergillus fumigatus (2.5×106 per mL) was assessed by XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) colorimetric assay. Error bars indicate sem for five healthy and five CF donors. *: p<0.05 (Mann–Whitney U-test).

  • FIGURE 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5

    Specificity of production of reactive oxygen species (ROS) against Aspergillus fumigatus conidia by phagocytes from healthy and CF donors. Polymorphonuclear cells (PMN) (a) (2.5×106 per mL) and peripheral blood mononuclear cells (PBMC) (b) (2.5×106 per mL) were stimulated with A. fumigatus conidia (5×107 per mL), 2 µm latex beads (5×107 per mL), depleted zymosan (200 µg·mL–1) and lipopolysaccharide (LPS) (50 ng·mL–1). Total ROS production is shown as the area under the curve (AUC) over 2 h (mean±sem) for five healthy and three CF donors. *: p<0.05 (Mann–Whitney U-test).

  • FIGURE 6
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6

    Effect of pre-treatment with lipopolysaccharide (LPS) or cystic fibrosis (CF) serum on the production of reactive oxygen species (ROS) by phagocytes from healthy and CF donors. ROS production by LPS pre-treated healthy and CF polymorphonuclear cells (PMN) (a) (2.5×106 per mL) and peripheral blood mononuclear cells (PBMC) (b) (2.5×106 per mL) was measured upon stimulation with Aspergillus fumigatus conidia (5×107 per mL), depleted zymosan (200 µg·mL–1) or 2 µm latex beads (5×107 per mL). Total ROS production, as calculated by the area under the curve (AUC) of relative light units (RLUs) by chemiluminescence over 1 h, is shown compared to non-primed controls. Error bars indicate ±sem for five healthy and three CF donors. Total ROS production by healthy PMN (c) (2.5×106 per mL) and PBMC (d) (2.5×106 per mL) incubated with 20% healthy or CF serum and stimulated with A. fumigatus conidia (5×107 per mL) or 2 µm latex beads (5×107 per mL) was also determined. Error bars indicate ±sem for five healthy donors.

  • FIGURE 7
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7

    Effect on production of reactive oxygen species (ROS) by polymorphonuclear cells (PMN) from healthy and CF donors on treatment with different sizes of bead and Pseudomonas aeruginosa. PMN (2.5×106 per mL) were stimulated with beads of different sizes (0.5–6 µm; 5×107 per mL), Aspergillus fumigatus conidia and P. aeruginosa. Chemiluminescence was measured directly for 2 h and total ROS production was calculated as the area under the curve (AUC). Error bars indicate ±sem for nine healthy and 11 CF donors. RLU: relative light unit. *: p<0.05 (Mann–Whitney U-test).

  • FIGURE 8
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 8

    Correlation of excessive reactive oxygen species (ROS) production to clinical disease severity. ROS production against Aspergillus fumigatus by polymorphonuclear cells (PMN) from 13 cystic fibrosis (CF) patients (compared to PMN from healthy patients) was correlated with the number of exacerbations in the previous year (a). Analysis was performed using Spearman's rank correlation coefficient (Spearman's rho). In addition, the 13 CF patients were divided into two groups based on percentage predicted forced expiratory volume in 1 s (FEV1) scores and their ROS production was compared. *: p<0.05 (Mann–Whitney U-test).

Supplementary Materials

  • Figures
  • Supplementary Material

    Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

    Supplementary material 00068-2017_Supplementary

PreviousNext
Back to top
Vol 4 Issue 2 Table of Contents
ERJ Open Research: 4 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity
Shan F. Brunel, Janet A. Willment, Gordon D. Brown, Graham Devereux, Adilia Warris
ERJ Open Research Apr 2018, 4 (2) 00068-2017; DOI: 10.1183/23120541.00068-2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity
Shan F. Brunel, Janet A. Willment, Gordon D. Brown, Graham Devereux, Adilia Warris
ERJ Open Research Apr 2018, 4 (2) 00068-2017; DOI: 10.1183/23120541.00068-2017
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Material and methods
    • Results
    • Discussion
    • Supplementary material
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • CF and non-CF bronchiectasis
  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original articles

  • Endobronchial autologous BM-MSCs in IPF patients
  • Effect of β-blockers on the risk of COPD exacerbations
  • Recurrence of symptoms after childhood LRTI
Show more Original articles

Cystic fibrosis

  • Functional assay in CF organoids allows drug repurposing
  • Nasal epithelial cell FRAP predicts CF therapy response
  • Diagnostic agreement in cystic fibrosis
Show more Cystic fibrosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society